Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Insulet Corp (NQ: PODD )

235.43 -3.37 (-1.41%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 607,132
Open 239.20
Bid (Size) 217.49 (2)
Ask (Size) 238.83 (1)
Prev. Close 238.80
Today's Range 232.01 - 239.65
52wk Range 125.82 - 243.98
Shares Outstanding 68,873,869
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Here's How Much $100 Invested In Insulet 15 Years Ago Would Be Worth Today
Via Benzinga
Analyst Expectations For Insulet's Future
Via Benzinga

Performance

YTD
+12.59%
+12.59%
1 Month
+30.29%
+30.29%
3 Month
+13.84%
+13.84%
6 Month
+39.16%
+39.16%
1 Year
+47.80%
+47.80%

More News

Read More
GE Vernova To Rally Over 30%? Here Are 10 Top Analyst Forecasts For Tuesday
Via Benzinga
Upstart, Insulet And 2 Other Stocks Executives Are Selling
Via Benzinga
Here's How Much $1000 Invested In Insulet 15 Years Ago Would Be Worth Today
Via Benzinga
Affirm, Mongodb And Best Buy Are Among Top 10 Large Cap Gainers Last Week (Aug 25-Aug 31): Are The Others In Your Portfolio?
Via Benzinga
(PODD) - Analyzing Insulet's Short Interest
Via Benzinga
Here's How Much You Would Have Made Owning Insulet Stock In The Last 10 Years
Via Benzinga
Why Insulet Stock Was Zooming Higher This Week
Via The Motley Fool
Stocks To Watch Today: PODD, SMCI, And PAYC
Via Talk Markets
Exposures Product Safety
Omnipod® 5 Automated Insulin Delivery System is now FDA-cleared for People with Type 2 Diabetes
From Insulet Corporation
Via Business Wire
S&P 500, Nasdaq 100 Snap 8-Day Winning Streak: What Triggered Wall Street's Setback On Tuesday?
Via Benzinga
Topics Stocks
Exposures US Equities
The Latest Analyst Ratings For Insulet
Via Benzinga
Peering Into Insulet's Recent Short Interest
Via Benzinga
Why NASDAQ:PODD Is a Promising High-Growth Stock in the Midst of Consolidation.
Via Chartmill
Insulet to Present at Upcoming Investor Conferences
From Insulet Corporation
Via Business Wire
Insulet Celebrates Grand Opening of 400,000-square-foot Manufacturing Facility in Malaysia
From Insulet Corporation
Via Business Wire
Wall Street Momentum Stalls After Thursday's Rally, Palantir Jumps To 3-Year Highs, Bonds Rally: What's Driving Markets Friday?
Via Benzinga
Stocks On Track For Weekly Losses Despite Midday Gains
Via Talk Markets
Topics Stocks
Exposures US Equities
Insulin Pump Maker Insulet's Growth Catalysts Set to Boost Revenue in 2025: Analyst
Via Benzinga
PODD Stock Earnings: Insulet Misses EPS, Beats Revenue for Q2 2024
Via InvestorPlace
Insulet Reports Second Quarter 2024 Revenue Increase of 23% Year-Over-Year
From Insulet Corporation
Via Business Wire
Wall Street Set For Uneventful Start Ahead Of Jobless Claim Data, VIX Rises: Strategist Says Market May Remain Vulnerable Until...
Via Benzinga
Topics Economy Stocks
Exposures Economy US Equities
Wall Street Rallies As Economic Concerns Recede, Tech Flexes Its Muscles, Semiconductors Soar: What's Driving Markets Thursday?
Via Benzinga
Chips, Glorious Chips!
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.